Relationship between metabolic control and self-monitoring of blood glucose in insulin-treated patients with diabetes mellitus.

Autor:	Soto González A; Servicio de Endocrinología y Nutrición, Hospital de A Coruña, La Coruña, España. Electronic address: alfonso.soto.gonzalez@sergas.es., Quintela Fernández N; Consulta privada, Medicina Interna, Santa Cruz de Tenerife, España., Pumar López A; Servicio de Endocrinología, Hospital Universitario Virgen del Rocío, Sevilla, España., Darias Garzón R; Servicio de Endocrinología, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, España., Rivas Fernández M; Servicio de Endocrinología y Nutrición, Hospital de Valme, Sevilla, España., Barberá Comes G; Departamento Médico de Sanofi, Barcelona, España.
Jazyk:	English; Spanish; Castilian
Zdroj:	Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion [Endocrinol Nutr] 2015 May; Vol. 62 (5), pp. 233-9. Date of Electronic Publication: 2015 Mar 23.
DOI:	10.1016/j.endonu.2015.01.010
Abstrakt:	Objective: To assess the relationship between metabolic control (MC) and frequency of self-monitoring of blood glucose (SMBG) in insulin-treated patients with type 1 (T1DM) and type 2 (T2DM) diabetes mellitus, and to analyze the factors associated to MC. Material and Methods: A multicenter, cross-sectional, observational study was conducted in which endocrinologists enrolled diabetic patients treated with insulin who used a glucometer. The cut-off value for MC was HbA1c ≤ 7%. Grade of acceptance of the glucometer was assessed using a visual analogue scale (VAS). Results: A total of 341 patients (53.5% males) with a mean age (SD) 52.8 (16.3) years, mean HbA1c of 7.69% (1.25) and 128 (37.5%) with T1DM and 211 (61.9%) with T2DM were evaluable. SMBG was done by 86.1% at least once weekly. No relationship was seen between MC and SMBG (P=.678) in the overall sample or in the T1DM (P=.940) or T2DM (P=.343) subgroups. In the logistic regression model, hyperglycemic episodes (Exp-b [risk] 1.794, P=0.022), falsely elevated HbA1c values (Exp-b 3.182, P=.005), and VAS (Exp-b 1.269, P=.008) were associated to poor MC in the total sample. Hyperglycemic episodes (Exp-b 2.538, P=.004), falsely elevated HbA1c values (Exp-b 3.125, P=.012), and VAS (Exp-b 1.316, P=.026) were associated to poor MC in the T2DM subgroup, while body mass index (Exp-b 1.143, P=.046) was associated to poor MC in the T1DM subgroup. Conclusions: In this retrospective, non-controlled study on patients with DM treated with insulin who used a glucometer, no relationship was seen between the degree of metabolic control and frequency of use of the glucometer. (Copyright © 2014 SEEN. Published by Elsevier España, S.L.U. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu